Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer

PHASE3RecruitingINTERVENTIONAL
Enrollment

454

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

June 30, 2028

Study Completion Date

June 30, 2031

Conditions
Intermediate Risk Non-Muscle Invasive Bladder Cancer
Interventions
DRUG

Nadofaragene Firadenovec

Vector-based gene therapy for NMIBC treatment to potentiate durable therapeutic responses by interferon (IFN) alfa-2b (IFN-α2b) amplification.

Trial Locations (43)

10010

RECRUITING

Veterans Affairs New York Harbor Healthcare System - Manhattan VA Medical Center, New York

10016

RECRUITING

Integrated Medical Professionals, PLLC, New York

10461

RECRUITING

Albany Medical College, Albany

10468

RECRUITING

James J. Peters VA Medical Center, The Bronx

11042

RECRUITING

Northwell Health -The Arthur Smith Institute for Urology, Lake Success

11530

RECRUITING

AccuMed Research Associates, Garden City

12603

RECRUITING

Premier Medical Group of the Hudson Valley, Poughkeepsie

14225

RECRUITING

Great Lakes Physician PC d/b/a Western New York Urology Associates, Cheektowaga

19004

RECRUITING

MidLantic Urology, Bala-Cynwyd

23462

RECRUITING

Urology of Virginia, Virginia Beach

29572

RECRUITING

Carolina Urologic Research Center, Myrtle Beach

30322

RECRUITING

Emory University, Atlanta

33771

RECRUITING

Advanced Urology institute - Pinellas, Largo

36606

RECRUITING

University of South Alabama (USA) Health System - USACM, Mobile

40536

RECRUITING

University of Kentucky (UK) - Markey Cancer Center, Lexington

45267

RECRUITING

University of Cincinnati, Cincinnati

56608

RECRUITING

Urology Associates of Mobile, Mobile

62301

RECRUITING

Blessing Health System, Quincy

63141

RECRUITING

Mercy Clinic Oncology and Hematology - David C. Pratt Cancer Center, Creve Coeur

67226

RECRUITING

Wichita Urology Group, Wichita

68114

RECRUITING

Adult and Pediatric Urology P.C., Omaha

77030

RECRUITING

Houston Methodist Hospital (Houston), Houston

90017

RECRUITING

American Institute of Research, Los Angeles

92563

RECRUITING

Urology Center of Southern California, Murrieta

92868

RECRUITING

University of California, Irvine, Orange

93720

RECRUITING

Urology Associates of Central California, Fresno

07960

RECRUITING

Atlantic Health, Morristown

L7N 3V2

RECRUITING

G kenneth Jansz Medicine Professional Corporation, Burlington

480-1195

RECRUITING

Aichi Medical University Hospital, Nagakute

466-8560

RECRUITING

Nagoya University Hospital, Nagoya

286-8523

RECRUITING

Japanese Red Cross Narita Hospital, Narita

791-0280

RECRUITING

National Hospital Organization Shikoku Cancer Center, Matsuyama

812-8582

RECRUITING

Kyushu University Hospital, Fukuoka

734-8551

RECRUITING

Hiroshima University Hospital, Hiroshima

317-0077

RECRUITING

Hitachi General Hospital, Hitachi

305-8576

RECRUITING

University of Tsukuba Hospital, Tsukuba

216-8511

RECRUITING

St. Marianna University Hospital, Kawasaki

236-0004

RECRUITING

Yokohama City University Hospital, Yokohama

783-8505

RECRUITING

Kochi Medical School Hospital, Nankoku

514-8507

RECRUITING

Mie University Hospital, Tsu

634-8522

RECRUITING

Nara Medical University Hospital, Kashihara

113-8519

RECRUITING

Institute of Science Tokyo Hospital, Bunkyō-Ku

641-8510

RECRUITING

Wakayama Medical University Hospital, Wakayama

Sponsors
All Listed Sponsors
lead

Ferring Pharmaceuticals

INDUSTRY